Adverse Events of Adjuvant Mitotane Treatment for Adrenocortical Carcinoma.
Ivana Dora VodanovicAnja Barač NekićLana ŠambulaKarin Zibar TomsicTina DušekDarko KastelanPublished in: Endocrine research (2024)
Careful monitoring and timely management are essential for ensuring mitotane treatment adherence and maximizing its benefits.